Ruolan Xia
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Chemokine receptors and signaling
-
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Maosen Xu (5 shared papers)Yuquan Wei (3 shared papers)Xiawei Wei (2 shared papers)Yang Wang (1 shared paper)Tao Zhang (1 shared paper)Xuelei Ma (5 shared papers)Yuwen Zhou (6 shared papers)Hong Qian (1 shared paper)
- Journals
- Frontiers in Oncology (1 paper)Frontiers in Molecular Biosciences (1 paper)Cell Proliferation (1 paper)Frontiers in Public Health (1 paper)European Journal of Surgical Oncology (1 paper)
- Partner nations
- China
In The Last Decade
Ruolan Xia
14 papers receiving 623 citations
Ruolan Xia's Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 285
- Immunology 172
- Cancer Research 76
- Hepatology 26
- Developmental and Educational Psychology 39
Countries citing papers authored by Ruolan Xia
This map shows the geographic impact of Ruolan Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolan Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolan Xia more than expected).
Fields of papers citing papers by Ruolan Xia
This network shows the impact of papers produced by Ruolan Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolan Xia. The network helps show where Ruolan Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruolan Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting Hit paper breakdown → | 2021 | 213 |
| 2 | Targeting the tumor stroma for cancer therapy Hit paper breakdown → | 2022 | 175 |
| 3 | Game-based learning in medical education Hit paper breakdown → | 2023 | 78 |
| 4 | 2021 | 42 | |
| 5 | 2022 | 38 | |
| 6 | 2020 | 30 | |
| 7 | 2022 | 21 | |
| 8 | 2021 | 11 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 8 | |
| 11 | 2023 | 3 | |
| 12 | 2022 | 2 | |
| 13 | 2025 | 1 | |
| 14 | 2022 | 1 |
About Ruolan Xia
Ruolan Xia is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Genetics, having authored 14 papers that have together received 631 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Research Studies (2 papers), Lung Cancer Treatments and Mutations (2 papers), Electrical Fault Detection and Protection (1 paper), Melanoma and MAPK Pathways (1 paper), Cancer Research and Treatments (1 paper), Hedgehog Signaling Pathway Studies (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Oncology (285 citations), Immunology (172 citations), Cancer Research (76 citations), Hepatology (26 citations) and Developmental and Educational Psychology (39 citations). Ruolan Xia has collaborated with scholars based in China. Frequent co-authors include Maosen Xu, Yuquan Wei, Xiawei Wei, Yang Wang, Tao Zhang, Xuelei Ma, Yuwen Zhou, Hong Qian, Xiuhe Zou and Yu Zhang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Molecular Biosciences, Cell Proliferation, Frontiers in Public Health and European Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.